MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Cytosorbents Corporation Cash and Cash Equivalents 2011-2026 | CTSO
Annual Cash and Cash Equivalents Cytosorbents Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.28 M | 14.1 M | 22.1 M | 52.1 M | 71.4 M | 12.2 M | 22.4 M | 17.3 M | 5.25 M | 5.32 M | 3.61 M | 2.18 M | 1.73 M | 1.19 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 71.4 M | 1.19 M | 16.7 M |
Quarterly Cash and Cash Equivalents Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.54 M | 10.2 M | 11.6 M | 3.28 M | 12.2 M | 14.9 M | 8.61 M | 14.1 M | 10 M | 14.8 M | 20.7 M | 22.1 M | 24.2 M | 31.9 M | 44.7 M | 52.1 M | 61 M | 65.6 M | 68.5 M | 71.4 M | 71.4 M | 71.4 M | 71.4 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 5.25 M | 5.25 M | 5.25 M | 5.25 M | 5.32 M | 5.32 M | 5.32 M | 5.32 M | 3.61 M | 3.61 M | 3.61 M | 3.61 M | 2.18 M | 2.18 M | 2.18 M | 2.18 M | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 1.19 M | 1.19 M | 1.19 M | 1.19 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 71.4 M | 1.19 M | 18.1 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M |  USA |
 |
LivaNova PLC
LIVN
|
636 M | $ 69.84 | 1.14 % | $ 3.79 B |  Britain |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 6.61 | 3.44 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
161 M | $ 13.85 | -0.57 % | $ 2.08 B | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
35.5 M | $ 31.25 | -3.85 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
19.3 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
43.7 M | $ 3.46 | -2.26 % | $ 120 M | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
488 M | $ 269.55 | 0.25 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
24.7 M | $ 4.63 | 3.58 % | $ 173 M |  France |
 |
Bruker Corporation
BRKR
|
183 M | $ 39.92 | 0.38 % | $ 5.95 K | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
1.96 B | $ 74.02 | -1.5 % | $ 110 B | USA |
 |
ClearPoint Neuro
CLPT
|
20.1 M | $ 15.18 | 4.3 % | $ 410 M | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 46.01 | -0.07 % | $ 1.43 B | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
68.9 M | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
32.4 M | $ 10.16 | 2.11 % | $ 290 M | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
15.3 M | $ 23.53 | 1.64 % | $ 199 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
90.3 M | $ 77.39 | -2.87 % | $ 2.18 B |  Costa-rica |
 |
Nano-X Imaging Ltd.
NNOX
|
213 M | $ 2.46 | 1.23 % | $ 144 M | Israel |
 |
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
46.8 M | $ 18.54 | -0.16 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
526 M | $ 95.57 | 3.99 % | $ 12.9 B | USA |
 |
Profound Medical Corp.
PROF
|
26.2 M | $ 7.35 | 2.79 % | $ 180 M | Canada |
 |
Helius Medical Technologies
HSDT
|
5.18 M | $ 2.18 | 17.84 % | $ 1.33 M | USA |
 |
IRadimed Corporation
IRMD
|
52.2 M | $ 100.38 | 1.3 % | $ 1.27 B | USA |
 |
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 11.54 | 0.09 % | $ 889 M | USA |
 |
Inogen
INGN
|
114 M | $ 6.07 | 3.94 % | $ 144 M | USA |